Evidence map›Paper›PMID 33896271›Full record

ArticleTechnology in cancer research & treatment

Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.

Xiaotao Su, Haoyu Li, Shaohua Chen, Chao Qin

Open access · goldAbstract read
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Dynein-Powered Cell Locomotion Guides Metastasis of Breast Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  5. Dynein-Powered Cell Locomotion Guides Metastasis of Breast Cancer.bioRxiv : the preprint server for biology · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xiaotao SuDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, China.ORCID 0000-0003-3710-1975
Haoyu LiDepartment of Ophthalmology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, China.ORCID 0000-0002-9826-181X
Shaohua ChenDepartment of Urology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, China.ORCID 0000-0002-4301-7254
Chao QinDepartment of Neurology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, China.ORCID 0000-0002-9965-2142
Guangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis present study aims to investigate the potential prognostic values of dynactin genes (

methodsThe

resultsOur research showed that the mRNA expression of

conclusionOur study showed that the high expressions of

Indexed as

Biomarkers, TumorBrainBrain NeoplasmsDatabases, GeneticDendritic CellsDynactin ComplexGene OntologyGliomaHumansKaplan-Meier EstimateLymphocytes, Tumor-InfiltratingMacrophagesMutation RateNeoplasm GradingNeutrophilsProgression-Free SurvivalBiomarkers, TumorDCTN1 protein, humanDCTN2 protein, humanDCTN3 protein, humanDCTN4 protein, humanDynactin ComplexRNA, Messengerbiomarkerdynactin proteinimmune infiltrationlow-grade gliomamutation

Identifiers

PMID33896271
PMCPMC8085377
OpenAlexW3159795465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.